Currently, there are 390.70M common shares owned by the public and among those 385.48M shares have been available to trade.
The company’s stock has a 5-day price change of -14.75% and -10.97% over the past three months. DXCM shares are trading -9.66% year to date (YTD), with the 12-month market performance down to -47.27% lower. It has a 12-month low price of $62.34 and touched a high of $142.00 over the same period. DXCM has an average intraday trading volume of 3.70 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -17.13%, -16.60%, and -17.12% respectively.
Institutional ownership of Dexcom Inc (NASDAQ: DXCM) shares accounts for 92.80% of the company’s 390.70M shares outstanding.
It has a market capitalization of $27.46B and a beta (3y monthly) value of 1.49. The stock’s trailing 12-month PE ratio is 49.32, while the earnings-per-share (ttm) stands at $1.42. The company has a PEG of 2.18 and a Quick Ratio of 1.28 with the debt-to-equity ratio at 1.23. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.05% over the week and 3.38% over the month.
Earnings per share for the fiscal year are expected to increase by 23.15%, and 22.53% over the next financial year. EPS should shrink at an annualized rate of 22.63% over the next five years, compared to 39.06% over the past 5-year period.
Looking at the support for the DXCM, a number of firms have released research notes about the stock. Redburn Atlantic stated their Buy rating for the stock in a research note on February 03, 2025, with the firm’s price target at $85-$115. Robert W. Baird coverage for the Dexcom Inc (DXCM) stock in a research note released on January 16, 2025 offered a Outperform rating with a price target of $104. Robert W. Baird was of a view on July 26, 2024 that the stock is Neutral, while JP Morgan gave the stock Neutral rating on July 26, 2024, issuing a price target of $145- $75. Redburn Atlantic on their part issued Neutral rating on May 30, 2024.
